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Abstract
Prescription stimulants like Adderall and Ritalin are increasingly being diverted and
misused by college students who fail to recognize the potential health risks in an effort to
improve academic performance. The main aim of this literature review is to address the
prevalence of their misuse, the effects they have on cognition, and adverse side effects that are
.D
,

edications remain mixed/unclear as to whether

cognitive domains such as memory, executive function, and processing speed are actually
enhanced. However, not surprisingly, it has been made clear that both individuals with ADHD
and individuals without ADHD see some benefit with regard to the cognitive domain of attention
when using prescription stimulants. On top of the need for further studies, there is much ethical
debate to be had regarding the use of these medications and their presence in academia and
society.
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Introduction
Caffeine, a substance found in everyday items such as coffee and energy drinks, is one of
the oldest and most commonly used stimulants in the world. It, like other stimulants, can impact
on levels while promoting feelings of wakefulness and
alertness through manipulation of neurotransmitters and their respective synaptic receptors in the
.U
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discovered until the early 1900s, where they were put to use in a variety of ways, including
weight loss programs, bronchodilation in asthma, promotion of alertness in the military,
symptom management in narcolepsy, and emotion control in depression.1 More recently,
however, prescription stimulants have been most commonly recognized as the first-line treatment
of attention-deficit/hyperactivity disorder (ADHD). In fact, the labeled indications for the most
common prescription stimulants are almost exclusively for the treatment of ADHD.4,5,6,7,8
Nowadays, prescription stimulants, like Adderall and Ritalin, are commonly referred to
,

,

.W

medications require a prescription from a healthcare provider regarding a medical diagnosis such
as ADHD, they are frequently misused based on the widespread belief that they enhance
performance. This has led to a steady increase in the rate of prescription stimulant misuse over
the past several decades and therefore deserves to be investigated due to potential public health
concerns.
Although prescription stimulants have proven to be successful in treating the symptoms
of ADHD, it remains unclear whether they convey an equal benefit to non-ADHD individuals.
Thus, the purpose of this paper is to answer the question: Do prescription stimulants enhance
cognition in individuals not diagnosed with ADHD? In addition to answering this primary
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question, other issues surrounding these medications, specifically related to the prevalence of
their misuse and adverse side effects typically associated with their use, will also be explored.
Following a background presenting the currently known research regarding prescription
stimulants will be a discussion of potential ethical implications that are connected to their use.
Granted the extensive pattern of prescription stimulant misuse, beliefs regarding their
performance enhancing capabilities, and their success in treating ADHD, it is hypothesized that
these medications do in fact hold some potential for cognitive enhancement in individuals not
diagnosed with ADHD. However, the scope of the level of enhancement is predicted to be
minimal and have a primary effect on the cognitive domain of attention.
Background
ADHD and Prescription Stimulants
Before we can determine the effects of prescription stimulants on non-ADHD
individuals, it is first important to understand the condition for which these medications are
commonly used along with some key features of the medications themselves. Therefore, this first
section aims to describe the prevalence and pathogenesis behind ADHD, while including names
and characteristics of several common prescription stimulants.
ADHD, characterized by the DSM-5 as a persistent pattern of inattention and/or
hyperactivity-impulsivity, is one of the most frequently diagnosed neuropsychiatric disorders in
children and adolescents.2 ADHD is most commonly seen in young boys and has been reported
to carry a prevalence of 10 percent amongst children aged 4-17 in the U.S.3 The condition

school due to persistent distractions and patterns of misbehavior.
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Although ADHD is historically a condition of youth and was previously thought to
diminish with age, it has become recognized as a condition that carries on into adulthood. In fact,
many epidemiologic studies estimate a prevalence of 4.4 percent in the U.S. and 3.4 percent
globally in individuals aged 18-44.2 Similar to the impact ADHD has on the education of
children and adolescents, ADHD in adulthood can confer remarkable disability, especially in
occupational and academic settings. Thus, it is important to accurately recognize and manage the
symptoms of ADHD in all age groups.
The diagnostic criteria that must be acknowledged before arriving at the diagnosis of
ADHD is the same in both children and adults.2 One unique difference, however, is that children
under the age of 17 years old
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-impulsivity to
17
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.2 Some

symptoms of inattention include difficulty sustaining tasks, reluctance to participate in tasks that
demand persistent mental effort, and being easily distracted by unrelated stimuli. Concerning
hyperactivity-impulsivity, symptoms include frequent fidgeting, excessive talking, and frequent
interruptions or intrusion on others. 2 On top of expressing the required symptoms, other key
features demand that the symptoms must interfere with daily functioning and have persisted for
at least the last 6 months.2
M

,

previously discussed along with the medications that control them. While the pathogenesis of
ADHD

,

metabolism in the prefrontal cortex, particularly of the catecholamines dopamine and
norepinephrine, plays an important role.3 This imbalance results in the neuropsychological
deficits related to executive function that are seen in individuals with ADHD such as inhibited
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memory and verbal learning, slowed information processing, lack of vigilance, and reduced
attention span.2 An increase in catecholamine metabolism therefore explains the widespread use
of stimulants in management of ADHD, which serve to counter the decreased levels of dopamine
and norepinephrine in the brain. Prescription stimulants include a long list of different
,

:
.

Dextroamphetamine-Amphetamine, commonly known by its brand name Adderall,
Dextroamphetamine, branded Dexedrine, and Lisdexamfetamine, or more well-known as
Vyvanse, are three amphetamine stimulants commonly used in the treatment of ADHD. Each of
these medications is classified by the Drug Enforcement Agency as a C-II controlled substance,
meaning that although they serve a medical purpose, they have a high potential for abuse and
dependence.4,5,6 With the exception of Vyvanse, they come in both short and long-acting
versions, which can vary in onset of action time from <1 hour to 2 hours and can maintain effect
from 4-16 hours after administration.9 Because both Adderall and Dexedrine are
sympathomimetic amines, they share a common mechanism of action that causes the release of
catecholamines (specifically dopamine and norepinephrine) from their storage sites in
presynaptic nerve terminals.4,5 Perhaps less significantly, but nonetheless an important aspect of
their function, they also have the potential to block the reuptake of catecholamines via
competitive inhibition.4,5 Comparatively, Vyvanse is a prodrug that eventually converts into
dextroamphetamine, where it then acts similarly to the other two medications by increasing the
amount of synaptic dopamine and norepinephrine.6
Methylphenidate, typically recognized as Ritalin or Concerta, and dexmethylphenidate,
branded Focalin, fall into the other subcategory of CNS stimulants that is frequently used in the
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management of ADHD. Similar to amphetamines, these medications are C-II controlled
substances and require close monitoring.7,8 Both of these medications come in short and longacting versions, with a typical range of onset of action between 0.5 and 2 hours and a duration of
effect lasting from 3 to 12 hours after administration. 9 Focalin is known to be more potent than
Ritalin because it both releases dopamine and norepinephrine into the extra neuronal space and
blocks their reuptake, whereas Ritalin only inhibits their reuptake.7,8
With regards to efficacy of these two categories of prescription stimulants in the
treatment of ADHD, a 2018 meta-analysis of 51 drug trials revealed a higher reduction of
symptoms in patients prescribed with amphetamines when compared to others who were
prescribed methylphenidate.10 However, despite being inferior to amphetamines in reducing
symptoms in patients diagnosed with ADHD, methylphenidate and dexmethylphenidate maintain
an overall higher safety profile.10 This is likely due to the fact that amphetamine products have a
stronger effect on dopamine and norepinephrine than methylphenidate products.
In sum, ADHD has a relatively high prevalence rate in the U.S. and may see some growth
due to increasing acceptance that the condition can occur amongst all age groups. The DSM-5, a
product of the American Psychiatric Association, has repeatedly been updated and should be
referenced when considering a diagnosis of ADHD. The symptoms included in the psychiatric
manual are widely believed to be a result of increased metabolism of dopamine and
norepinephrine and are therefore best treated with prescription stimulants, such as Adderall and
Ritalin, which serve to create a normal balance of synaptic catecholamines.
Diversion and Misuse of Stimulants
Now that we know more about common prescription stimulants and the condition for
which their use is indicated, le

.
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This section will review the prevalence of misuse of prescription stimulants, who is misusing
these medications, risk factors leading up to misuse, how the drugs are acquired, and motivations
for misuse.
T

,

.T

N

Survey on

Drug Use and Health defines misuse as use of a prescription medication in any way not directed
,
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greater amounts and/or frequencies, use to get high, and selling or sharing with others.11
Conversely, prescription use is defined as the utilization of a prescription medication in the
manner instructed by the prescribing physician.
As mentioned earlier, prescription stimulants are categorized by the Drug Enforcement
Agency as C-II controlled substances. Meaning that, despite their positive effect on treating
certain medical conditions, they run a high risk for misuse that can lead to addiction and
dependence, amongst other consequences, as a result of their actions on the reward center of the
brain.11 Shockingly, some laboratory studies have revealed that animals, when given the
opportunity, will repeatedly dispense methylphenidate, similarly to how they would with
cocaine, due to its euphoric effect when taken in higher doses.13 So, like many other C-II drugs,
such as opioid analgesics and benzodiazepines, stimulants have found a place in the black market
to be used and sold illicitly.
The rate of stimulant prescriptions for the treatment of ADHD has steadily increased over
the past few decades. In fact, the rate of prescriptions more than doubled from 0.6 percent in the
1980

2.7

1997.12 A more recent study that was conducted in 2016 revealed

past-year prescription rates as high as 6.4 percent in the United States.11 This increase in
prescriptions is thought to be mostly due to advances in psychiatric diagnostic practices and an

9

overall increase in duration of treatment of ADHD that extends well into adulthood. 13,14 These
findings are important because the increase in prescription rates is directly related to the
increased rate of misuse due to a resulting widespread availability and diversion of these
medications. In 2000, prescription stimulant misuse, specifically regarding methylphenidate, was
reported to have a past-year prevalence of 1.2 percent.14 A later investigation unveiled a 67
percent increase in the misuse of prescription stimulants between 2006 and 2011 that was
accompanied by a roughly 156 percent increase in emergency room visits related to misuse.12
Most recently, a 2016 study found an overall past-year prevalence of misuse to be 2.1 percent of
the general population in the United States.11
There is a wide variety of types of people who misuse prescription stimulants, from
athletes and the general public, to college students and even individuals diagnosed with ADHD
who hold a valid prescription. The vast majority of research, however, has identified
undergraduate college students as the primary group when it comes to misuse, specifically
individuals aged 18-25.11,12,13,14 In fact, studies have shown that nonmedical use of prescription
stimulants is the second most common form of illicit drug use amongst college students,
following marijuana.13,14 One study quoted a coll
R

,
.

13 A

A

survey conducted in 2003 of

a random sample of 9,161 undergraduate students attending a public university in the U.S.
reported a rate of illicit use of 8.1 percent.13 Interestingly, this number was higher than
individuals who reported prescription use related to a diagnosis of ADHD.13 Ultimately, most
studies appear to indicate an overall prevalence of prescription stimulant misuse in the range of 5
to 6 percent amongst traditionally aged college students.11
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The frequency at which college students misuse prescription stimulants is another
important matter. A 2002 study found that out of a 35.3 percent past-year prevalence rate, 10
percent used monthly and 8 percent used weekly.19 To break it down further, a 2006 study
showed 15.5 percent using 2-3 times per week and 33.9 percent using 2-3 times per month.19
Other studies showed more rates of irregular use of prescription stimulants with 40 percent only
using once or twice in a lifetime, which were reported to be due to particularly stressful times
related to academic pressures.19
Although undergraduate students have been the focus of most of the studies on the
misuse of prescription stimulants, graduate students have begun to receive an increasing amount
of attention. Several studies conducted over the past two decades have directed the spotlight on
health professional students, some of which include medical students, pharmacy students, and
dental hygiene students. Separate studies revealed that over 10 percent of medical students, 7
percent of pharmacy students, and 12.4 percent of dental hygiene students reported misusing
prescription stimulants.14 Another study of overall graduate students reported a lifetime
prevalence of nearly 17.5 percent. 12
Risk factors that make an individual more susceptible to misusing prescription stimulants
include attending college, male gender, white race, age 18-25, affiliation with a fraternity, lower
grade point average, living in off-campus housing, previous exposure, and having a history of
substance abuse. 13,14 Curiously, individuals who were initiated on prescription stimulants for the
management of ADHD during high school or college were three to seven times more likely to
report illicit use than individuals who were never prescribed stimulants.13 Conversely, students
initiated on stimulant medication for treatment of ADHD during elementary school reported a
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lower probability of illicitly using their medication when compared to individuals who were
never prescribed stimulants.13
The majority of nonprescription stimulant users stated they acquired the medications
from friends and peers, while only a few received them from family members.13,14 Notably, less
than 1 percent of students mentioned obtaining prescription stimulants from a dealer.13A 2008
study found that lifetime rates of diversion ranged from 16 to 29 percent, while another study
found 54 percent of college students with valid prescriptions for stimulants had been solicited to
divert their medication. 13,14 Another study demonstrated that due to widespread popularity of
these medications, roughly 29 percent of 334 participating college students sold or gave their
prescription stimulants to others. 14
Studies consistently indicate the main motivation for misusing prescription stimulants
amongst college students is cognitive and academic enhancement. A 2011 study on medical and
health profession students found that 93.5 percent of students who were misusing prescription
stimulants stated their objective was to increase focus and concentration on studying. 14 This is
particularly notable at the end of a school semester when students find themselves under
immense academic stress and often resort to taking these drugs to study through the night and
complete projects.14 Other less reported reasons for taking prescription stimulants include weight
loss, curiosity, coping with stress, staying awake, and recreational use to get high. 12,14
Recreationally using prescription stimulants to get high is of particular concern due to a
sequentially higher dose to produce the desired euphoric response, which poses a higher risk for
adverse health effects.
In closing, this section has identified an increasing prevalence of not only prescription
stimulant misuse, but also medically indicated prescription use. It is likely that increases in both
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of these areas is directly related, where the increase in prescription use has led to the increase in
prescription misuse by way of medication diversion. Although college undergraduate students
are the primary misusers of prescription stimulants, studies have identified graduate students as a
second group with high rates of misuse. These groups appear to be misusing prescription
stimulants primarily in an effort to enhance their academic performance and have likely

used prescription stimulant medications.
Cognition and Cognitive Assessments
Being that cognitive and academic enhancement is consistently reported to be the main
,
is actually achievable. Therefore, the purpose of this section is to put clarity behind the term,
cognition, and briefly describe how this term is broken up into individual aspects. Secondly,
several commonly used psychological tests that are frequently used in the assessment of
cognition will be identified and described.
Simply put, cognition is the mental process by which humans acquire, understand, and
interpret knowledge that they are exposed to. Moreover, cognition is broken up into several key
domains, which include sensation, perception, motor skills and construction, attention and
concentration, memory, executive functioning, processing speed, and language/verbal skills. 21
Although there may be overlap and difficulty in clearly separating each of these interconnected
domains, they can be further broken down into unique subcategories (e.g. executive functioning
consists of reasoning, problem solving and component skills management), which is helpful in
.I
that most current studies addressing the impact of prescription stimulants on cognition did not
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assess all of the cognitive domains. Rather, studies selected to assess cognitive areas that were
thought to be most relevant to ADHD and academic performance. Specifically,
attention/impulsivity, memory, executive function, and processing speed were repeatedly
mentioned in a number of studies.
As one might imagine, decades of clinical research have produced a vast number of
psychological tests aimed at assessing cognition and each of its individual domains. And, while
many of the existing cognitive tests have been utilized in the evaluation of ADHD and the effects
of prescription stimulants, four particular tests have been repeatedly used amongst studies. These
tests include the continuous performance task, digit span task, Wisconsin card sorting task, and
digit symbol substitution task.
Although the continuous performance task (CPT) is primarily used to assess
attention/impulsivity, it has also been used in some studies to assess memory and processing
speed. CPT can be administered to a subject in a variety of ways, but each format typically
consists of requesting the subject to detect simple isolated stimuli while simultaneously being
exposed to a separate, constant flow of distractor stimuli.21 The subject is graded based on a
combination of appropriate detections of the isolated stimuli, missed detections (errors of
omission), inappropriate detections of the distractor stimuli (errors of commission), and reaction
time.21 This is one of the most commonly used tests in the assessment of ADHD and can be
presented at multiple levels of intensity.
The digit span task (DST) assesses memory. This task involves presenting the subject
with an increasingly growing sequence of numbers and then requesting the subject to repeat that
sequence in the same order, in reverse order, or both. 15,21 This task can vary in the quantity of
numbers presented as well as in the timeframe in which the subject is expected to recall the
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sequence.15,21 The subject is graded based on the size of the number sequence they were able to
successfully recall.15
The Wisconsin card sorting task (WCST) assesses executive functioning, while
expressing particular concern for its cognitive flexibility, reasoning, and problem solving
aspects.16,21 The subjects of this assessment are instructed to infer a particular pattern by
.16,21 The cards will each share similarities,
but they will not be exact pairs. Success of this task demands that the subject consider new and
unique strategies upon failed card matching attempts as indicated by the examiner. 21 The subject
is graded based on the amount of errors produced and their ability to learn from their mistakes.
Lastly, the digit symbol substitution task (DSST) assesses processing speed. Subjects of
this task are provided with a list of numbers that each correspond to a unique symbol. 16 Upon
brief familiarization with the list, a symbol will be revealed to the subject. 16 The subject is then
supposed to refer to the list as a key in order to correctly match the symbol with its equivalent
number.16 Granted this task assesses processing speed, the subject is expected to perform as
quickly as possible and is graded based on a combination of time used and the amount of correct
responses.16,21
To summarize this section, cognition was defined and broken up into the individual
domains of sensation, perception, motor skills and construction, attention and concentration,
memory, executive functioning, processing speed, and language/verbal skills. Per their
relationship with the pathophysiology of ADHD, four commonly studied cognitive domains are
attention/impulsivity, memory, executive function, and processing speed. While each of these
domains is very much connected to the others, several psychological tests exist to isolate and

15

assess the functioning of each individual one. Respectively, the four emphasized domains are
assessed by CPT, DST, WCST, and DSST.
Impact of Prescription Stimulants on Cognition in Individuals with ADHD
This section aims to describe the symptomatic improvements seen by individuals with
ADHD who are using prescription stimulants. Importantly, the cognitive baseline held by
individuals with ADHD will be addressed, followed by research findings related to the impact of
prescription stimulants on specific cognitive domains and their effect on academic performance.
Lastly, a dose-response relationship between prescription stimulants and specific cognitive
domains in individuals with ADHD will be discussed.
Inherently, individuals diagnosed with ADHD have certain behavioral and cognitive
deficits. Specifically, these individuals lack in the areas of selective attention, impulsivity,
memory, reaction time, information processing speed, and executive control.14 Thus, the
cognitive baseline held by children and adults with ADHD is said to be lower than individuals
not diagnosed with ADHD. For this reason, it is important to recognize that improvements found
in individuals with ADHD resulting from the treatment of prescription stimulants is seen through
a lens of normalization, rather than one of enhancement.20,22
Having acknowledged a lower starting cognitive baseline amongst individuals with
ADHD, it is not surprising to reveal that the majority of studies found overall increased rates of
cognitive improvements with prescription stimulants, particularly regarding attention,
impulsivity, memory, and reaction time.20,22 Of note, executive function did not see any
enhancement. When comparing stimulant use in ADHD to non-ADHD, reports suggest a similar
upward trend in some areas of cognition, but that there is far more impact to be had when the
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cognitive baseline is already low to begin with. Undoubtedly, it is for this very reason that
prescription stimulants continue to be the first-line treatment option for the symptoms of ADHD.
Although students with ADHD appeared to experience more of a positive cognitive effect
by using prescription stimulants than did their non-ADHD counterparts, they did not
academically outperform them. In fact, studies have shown that even though prescription
stimulants may increase their note taking, scores on quizzes, homework completion, and overall
academic productivity, individuals with ADHD tend to utilize more remedial academic services,
repeat or withdraw from courses, and are less likely to attend college in general.14 One study
comparing grade point averages discovered that college students with ADHD had statistically
lower averages than non-ADHD students.22 Therefore, these results tend to indicate that although
academic improvement is seen in students with ADHD who take prescription stimulants, they
still seem to achieve less academically than non-ADHD students. This is likely due to
unimpacted deficits in the area of executive function, which ultimately helps control other
cognitive domains and is key to problem solving.
Interestingly, a study from the late 1970s suggested the dose required to produce the
optimal cognitive effects was lower than the dose required for desired behavioral effects. 20 T
to say, a higher dose is required to produce the effects visible to others. Several studies have
since shown a dose dependent response to prescription stimulants based on which type of task an
individual was asked to perform.20 For example, individuals with ADHD responded better in the
areas of attention and memory when administered higher doses of a stimulant. Whereas, no
benefit was observed from receiving a higher dose in areas such as executive functioning and
motor speed.20 Most dose response studies regarding optimal cognitive and behavioral effects of
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stimulants have revealed a high level of variability, indicating the importance for patient
customization based on specific deficits.20
To come to the point, individuals who are diagnosed with ADHD maintain an overall
lower cognitive baseline than their non-ADHD counterparts. Recognizing this difference is
important when comparing the effects of prescription stimulants between the two groups.
Perhaps predictably, the cognitive domains of attention, impulsivity, memory, and reaction time
saw the most benefit from taking prescription stimulants. And, although overall academic
improvements were reported, individuals with ADHD did not see the same level of academic
achievement as non-ADHD individuals. Lastly, a dose-response relationship between
prescription stimulants and specific cognitive domains in individuals with ADHD was identified
early on and indicates the value of tailoring prescription stimulant doses to the unique deficits of
each patient.
Impact of Prescription Stimulants on Cognition in Individuals without ADHD
Opposite to the previous section, the goal here is to identify the effects of prescription
stimulants in individuals who have never received a medical diagnosis, and who are therefore
misusing these medications. To start, the subjective views of the effects of prescription
stimulants held by non-ADHD college students will be mentioned, followed by study results as
they relate to the four cognitive domains of interest.
There are numerous anecdotal reports made by college students claiming the cognitive
benefits of prescription stimulants. But, as one might infer, many of these claims could very well
be the result of the placebo effect. Wherein the student simply believes that he or she had
enhanced cognitive abilities due to hearsay regarding the prescription stimulant they consumed.
Another possibility is that the student may have improved their quality and quantity of work
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simply due to a resulting increase in energy, wakefulness, and motivation that was produced by
the prescription stimulant, rather than an enhanced cognitive ability.19 Responses from a 2014
survey of 18 healthy university students regarding subjective experience of enhancement and
objective academic results indicated mixed results.18 Concerning the subjective experience, one
, I
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-term memory and then
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were inconsistent answers, however, when it came to

actual academic results, where most students reported good results, a few reported complete
confidence that the stimulant helped them, and others saw no improvement in their grades. 18
Obviously, the results of this survey indicate a strong pattern of belief in prescription stimulants,
but confirms that there is a lack consistency when it comes to actual academic results. Not to
mention, academic results could be related to many factors other than the medications, such as a
variance in studying styles, time allowed in advance to study, and a difference in overall
cognitive baselines.
Putting subjective student reports aside, most studies produced results indicating either
minor cognitive enhancements, no enhancement, or mixed/unclear results, with no studies
reporting high levels of cognitive enhancement. Predictably, with respect to the domain of
attention, there was an overall consensus that individuals not diagnosed with ADHD experienced
a minimal to moderate increase when using prescription stimulants.14,15,17 When assessing
participants with CPT, results of three studies indicated a significant decrease in errors of
omission, meaning the participants were less distractable.14,17 Four studies saw decreased
,

.14,17 And lastly, one study
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reported marginally decreased errors of commission, which can be interpreted as a decrease in
impulsivity when posed with irrelevant stimuli.15
Unlike attention, studies of prescription stimulants on memory appeared to demonstrate
higher amounts of mixed/unclear results. Studies from 2002 and 2015 on memory and stimulant
use via DST reported a small, yet significant improvement in partici

.12,17,19 This

was on par with the results of three earlier studies which, through the implementation of
assessments other than DST, also reported slight increases in memory. 14,17 Conversely, though,
various other studies using DST indicated that stimulants had no effect on memory.14,19 Finally,
only one study, conducted in 2018, cited a slight impairment in the memory of participants
taking a stimulant when compared to the placebo group via DST.15
I

gnitive domain is the most complex and

broad of the cognitive domains and encompasses many subcategories.21 Most studies found
common ground, though, in focusing on a single form of memory: working memory. Working
intain and manipulate information for conscious use.21
In comparison to other long-lasting forms of memory, one literature review describes working

out varied tasks.19 Perhaps its applicability to academic performance is why many studies chose
to concentrate on this form of memory.
Again, in the assessment of executive function, most studies produced mixed/unclear
results. Using WCST in 1996 and later in 2003, a study conducted by a group of the same
authors concluded that prescription stimulants had no effect on executive function.14,19 To the
contrary, a systematic review that included data from a 2009 study using WCST noted fewer
perseverative errors amongst participants using stimulants, meaning participants were able to
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successfully deduce patterns and problem solve better than their placebo counterparts. 17
However, a commonly referenced study from 2010 noted an increase in perseverative errors
amongst participants who underwent WCST, indicating stimulants result in a decreased cognitive
flexability.12 These results are on par with those mentioned previously regarding individuals with
ADHD,

utive function.

Lastly, and perhaps the least studied of the four cognitive domains included in this
review, is processing speed. Studies targeting this area yielded results indicating an overall
positive relationship between prescription stimulants and processing speed, where participants
were able to more quickly and accurately match numbers to their equivalent symbols in DSST.
The primary study of reference is a 2016 meta-analysis that extracted data from 8 different DSST
studies for a total of 345 subjects, revealing a small, but significant improvement in processing
speeds amongst participants.12,16
In summary, the results of studies showing the effect of prescription stimulants on
cognition in individuals not diagnosed with ADHD are fairly mixed and unclear. Although it was
not a unanimous decision, and considering the possibility of the placebo effect, the majority of
college students misusing these medications are under the impression that they benefited from
their use. Academic grades, however, illustrate a mixed story, where not everyone earned the
grade they expected as a result of taking prescription stimulants. Furthermore, three out of the
four cognitive domains emphasized in this paper expressed variable results that range on the
spectrum from positively impacted to unfavorably impacted, while only one domain, attention,
exhibited concordant results of a positive impact.
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Adverse Effects of Prescription Stimulants
In accordance with increasing amounts of prescription stimulant use, whether it be under
the guidance of a physician or not, it is important to review the common adverse effects often
associated with their use. While the adverse effects of prescription stimulants may hold some
variance, they can usually be predicted based on their mechanism of action in the sympathetic
nervous system. The expected side effects of a normally prescribed dose typically include an
increase in blood pressure, increased heart rate, increased body temperature, decreased sleep,
decreased appetite, and dry mouth.11 Higher quantities, on the other hand, can result in a
dangerous overdose. Signs leading up to an overdose can include mydriasis, tremor, agitation,
hyperreflexia, combative behavior, confusion, hallucinations, paranoia, and seizures. 11 And
although rare when compared to prescription opioids, death may result from stimulant overdose.
In fact, following a one-year increase in mortality of 33 percent in the United States, 2016 saw
over 7500 deaths related to prescription stimulant overdose.11 Out of the population that
represents the recent 33 percent increase in mortality, younger males aged 15 to 24 years saw the
biggest jump.11
Perhaps the most concerning side effects of prescription stimulant use relate to the
cardiovascular system. One might presume that persistent elevations in blood pressure and heart
rate, especially after prolonged use, would be a direct cause of other conditions such as
hypertension, myocardial infarctions, arrhythmias, cardiomyopathies, and sudden death. In fact,
a recent study of 125 adult subjects diagnosed with ADHD who were treated with prescription
stimulants resulted in persistent elevations in both systolic and diastolic blood pressures ranging
from 3 to 5mmHg and was accompanied with an average increase in heart rate of about 5bpm
when compared to baselines.9 These seemingly inherent elevations in cardiovascular vital signs
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would almost certainly imply a future need for antihypertensive medications, especially in
individuals who were already elevated or borderline hypertensive before starting on prescription
stimulants.
In an effort to address the risk of experiencing adverse cardiovascular events while using
prescription stimulants, 7 out of 10 large studies included in a 2012 systematic review concluded
that there was no association.23 To break down the demographic targeted by these studies, 7 were
based off of ADHD affected children and adolescents with ages ranging from 2 to 24 years and
only 3 were based off of ADHD affected adults ranging from 18 years of age and older.23
Amongst the studies aimed at children, 6 out of the 7 found no association between adverse
cardiovascular events and prescription stimulant use, while 2 out of the 3 studies aimed at the
adult population did find some level of association.23 These studies are important and should be
referenced when considering the use of prescription stimulants, especially in older individuals
who already have naturally higher risks for cardiovascular conditions due to wear and tear.
Similarly, a different review that was also published in 2012 pointed out several cases of
cardiac arrhythmias and infarction found in young adults taking prescription stimulants.14 One
case described a 20-year-old male college student who suffered a myocardial infarction
following the ingestion of two 15 mg Adderall XR tablets.14 The same situation occurred in a 15year old boy who took two 20 mg tablets of Adderall.14 While it is important to acknowledge
such cases, it is also important to note that this review focused specifically on individual
instances that were related to doses above the minimum, whereas the previous review focused on
large population-based observational studies. Nonetheless, there is definitely a potential for
adverse cardiovascular effects, which points to the importance of being properly evaluated for
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cardiac symptoms and history prior to induction and followed by regular pulse and blood
pressure monitoring throughout use.9
A second, more rare concern regarding prescription stimulants is the potential for
developing a drug related psychosis. Interestingly, psychosis borders the opposite side of the
spectrum when compared to the cognitive enhancing properties that make prescription stimulants
so sought after by university students in the first place. Onset of psychosis is believed to be the
result of excess dopamine in the neuronal synapses.14,24 Therefore, one could infer that the risk
for developing psychosis is related to taking a higher dose of prescription stimulants. A study
from 2019 identified 343 cases of psychosis out of a total of 337,919 participants who used a
prescription stimulant.24 Of those 343 cases, roughly 31 percent were related to methylphenidate
and 69 percent were related to amphetamines.24 This makes sense since dopamine release is 4
times more potent with amphetamines than with methylphenidate, which primarily blocks the
reuptake of dopamine.24
L

,

regards to prescription stimulants. These medications have the ability to produce pleasurable and
motivational dopaminergic responses that are key to addiction formation and have the ability to
act similarly to illicit drugs such as cocaine and methamphetamine. Although the risk of
addiction is not entirely clear, one study from 2006 estimated that roughly 1 in 20 (5 percent)
users of prescription stimulants for reasons other than ADHD meet the criteria for dependence. 19
And, among individuals who went through substance use treatment in 2019, 3.4 percent were for
prescription stimulant use.11 Notably, while reports of individuals with ADHD abusing their
prescription stimulant medications exist, labelled use does not appear to increase the overall risk
of developing a substance abuse disorder.13 In fact, it has been reported that prescription
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stimulants have a protective quality against ensuing substance abuse disorders in ADHD affected
individuals.13 This protective effect is likely a result of controlling impulsive behaviors typically
found in ADHD.
In sum, the sympathomimetic impact of prescription stimulants conveys certain
cardiovascular side effects on the human body. Specifically, stimulants have been shown to
persistently elevate both blood pressure and heart rate over time. This carries important
implications with respect to the potential of developing hypertension and heart failure with
chronic use. And, while the majority of studies on children and adolescents have concluded there
is no association between prescription stimulant use and adverse cardiovascular events, such as
myocardial infraction and arrhythmias, cases of sudden death related to their use do exist in the
literature. Adults, on the other hand, appear to have a higher overall association with the risk of
experiencing adverse events. Therefore, it is essential to be properly evaluated prior to beginning
use of prescription stimulants and maintain a good follow-up schedule to monitor vital signs.
Lastly, the issue of substance abuse and dependence is of growing importance due to the
addictive qualities exhibited by prescription stimulants and their growing rate of use.
Methods
Relevant literature was identified through searches on PubMed and UpToDate using
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An examination of titles and abstracts was conducted to include only pertinent
publications. Initially, 36 sources were identified, but many were eventually excluded from the
investigation due to lack of available full-length articles. Ultimately, 26 sources were reviewed,
analyzed, and included in this investigation.
Discussion
The information presented in the background section confirms that the prevalence of
prescription stimulant misuse continues to rise despite persistently mixed results of their efficacy
in the realm of cognitive enhancement. While the results of many scientific studies regarding this
topic in non-ADHD individuals do appear to indicate a slight positive trend in some areas of
cognition, an equivalent number pointed towards a null effect, and a small number of studies
indicated a negative effect. This leaves a lot of room for questions and interpretation surrounding
this area and certainly indicates the need for further research to produce more definitive results.
One concerning pitfall identified in many studies and reviews is an absence of
concordance with regard to a shared cognitive baseline of study participants. Although this
aspect may be difficult to gauge, it is arguably the most important factor in determining the
effect of prescription stimulants on cognition. One prominent study of ADHD affected
in

, B

,

reasonable to assume that some unknown proportion of the diagnoses were questionable. Even
though we required that all participants provide a prescription for stimulants before they could be
,

.
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The same authors also

acknowledged the possibility that non-ADHD participants could have been diagnosed with
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ADHD had they been evaluated. It is likely that this was not the only study to make assumptions
of its participants regarding their cognitive baseline. It is important to maintain a certain level of
trust in the diagnostic capabilities amongst colleagues, but it is equally important to doublecheck diagnoses when in doubt, especially when attempting to arrive at conclusions in medical
studies.
Furthermore, key terms also lacked common definitions in many of the existing studies
regarding this topic. Amongst those are common dosages and frequency of specific prescription
stimulants used, prior study habits and personality traits of participants, and the meanings of
cognition and specific cognitive domains. Although each of these variables is important to
arriving at one conclusion, describing the individual cognitive domains differently makes it
particularly difficult to understand what is even being assessed in the first place. As an example,
some studies referred to executive function specifically as cognitive flexibility, whereas others
referred to cognitive flexibility and executive function as separate domains. And even though
,
.
Another important point to mention regarding the methods of most of these studies is that
there was a strong lack of consistency when it came to types of assessments performed. Although
this literature review attempted to isolate 4 specific psychological tests (CPT, DST, WCST,
DSST) and provided a description of how they functioned, more than 20 other tests were
identified amongst studies. This leads to a high amount of variability when trying to compare and
contrast the results and arrive to an informed conclusion. It is imperative that future studies
define which assessments best reveal the effects of prescription stimulants on cognition and stick
to a select few rather than implementing a huge variety.
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Of the four cognitive domains that were most emphasized in this investigation,
attention/impulsivity appeared to receive the most benefit in both ADHD and non-ADHD
individuals. This of course is not entirely surprising, seeing that the main purpose of prescription
stimulants in medicine is to reduce symptoms of inattention in ADHD. Perhaps, however,
enhancement in this area is of particular importance to most students and other individuals both
using and misusing prescription stimulants. Afterall, it was reported that the majority of college
aged students misusing these medications did so in times of greater academic pressures related to
studying for multiple exams and other end of the year projects. Certainly, granted the high
amount of overlap and interconnection amongst the domains that ultimately define cognition,
one could argue that attention is most related to learning in that it allows the user to spend more
time focused on a desired subject and therefore achieve more academic and career goals. Even if
,
increased level of attention over time impact them? For example, even if memory may not be
enhanced, meaning that one could memorize more information in a shorter period of time,

remember more information.
Despite the fact that there is still no clear answer regarding the overall cognitive
enhancing capabilities of prescription stimulants, it is likely that they will continue to be
misused. Therefore, it is crucial to address the multiple ethical concerns surrounding their use.
Specifically, what is the role of the healthcare professional in prescribing and managing these
medications? Do the benefits of prescription stimulant use outweigh the risks? How should they
be treated within academia? Where do these medications fall in the eyes of society? The answers
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to these questions are very complex and undoubtedly require the viewpoint from a variety of
different angles.
The typical healthcare professional with prescriptive authority will inevitably find
themself in a position where they are considering prescribing a stimulant medication such as
Adderall or Ritalin. This may happen upon arriving at the diagnosis of ADHD in a young child
who has expressed an inability to pay attention in class and whose grades are suffering as a
result. Perhaps a stressful appearing young college student is seeing his primary care provider for
the first time in years expressing similar symptoms of inattention and impulsivity. Or maybe the
provider is approached by a healthy patient who openly states that they just want a prescription
A

.R

,

the discretion of the provider to decide on how to move forward.
A 2013 article q

A

A

N

(AAN)

,

medications for cognitive enhancement is not ethically obligatory or prohibited, and is therefore
ethically permissible, but that refusing to prescribe is also ethically and legally permiss

.
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Notably, though, the AAN followed this by also emphasizing the importance of evidence-based
medicine when prescribing stimulants for off-label use.25 Although helpful, this leaves little
official guidance for healthcare professionals and is merely suggestive of two possibilities. The
first, and most obvious, is to be a careful and thoughtful diagnostician in order to properly arrive
at an evidence-based conclusion before writing a prescription for stimulant medications. The
second possibility, while not mutually exclusive from the first, points more towards a dynamic of
trust between the healthcare professional and the patient, where the prescriber must believe the
patient will safely use, and most importantly, benefit from taking the prescription stimulant,
regardless of a diagnosis.
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As mentioned earlier, the current data (excluding the domain of attention) remains
unclear as to whether a healthy individual would actually benefit from prescription stimulants.
Obviously, this would imply that when referencing evidence-based medicine, the healthcare
.H

,

healthy patient specifically states he or she would like to be prescribed a stimulant specifically to
enhance attention. Granted that attention is the only domain with unanimous support of
enhancement, should this patient receive a prescription? One could argue that since attention has
proven to be enhanced by use of prescription stimulants that the patient might be a good
candidate for its off-label use, of course allowing that the prescriber expresses no concern that
the patient is at risk for any adverse drug effects. It could be further argued that increased
attention would convey more academic, professional, and economic success, leading the patient
to be able to afford a healthier lifestyle that might otherwise be limited. On the other hand,
deciphering the intentions of a patient and gaining a high level of trust could prove to be a very
difficult task, especially in a world where malingering is commonplace.
Furthermore, the healthcare professional would certainly have to weigh the risks of
adverse effects that are associated with prescription stimulant use. Despite being a generally safe
medication when used under the guidance of a healthcare professional, prescription stimulants
have shown to carry certain risks, especially related to the cardiovascular system. And although
the majority of studies mentioned in this review have concluded that there is no increased risk of
adverse cardiovascular events associated with prescription stimulant use, it was not arrived at
unanimously. Afterall, the FDA has committed a black box warning to several commonly
prescribed stimulants for risk of sudden death, which, in spite of being relatively rare, should not
be taken lightly and need to be strongly considered before prescribing a stimulant medication. It
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might also be hard to believe that a medication associated with persistent elevations in heart rate
and blood pressu

.F

,

also important to consider what the future holds for a patient who chronically uses these
medications.
Concerns of addiction and dependence are another concern when it comes to prescription
stimulants. Based on their classification as C-II controlled substances, it is clear that prescription
stimulants pose a threat to developing addictive behaviors. Arguably, though, more studies need
to be conducted surrounding the addictive properties of these medications. Nonetheless, it is
crucial that healthcare professionals take an insubstance use history prior to initiating any treatment involving stimulant medications.
Falling outside the court of medical professionals lies a more societal view of
prescription stimulants as it pertains to their potential to be used as cognitive enhancers. Granted
,

have been

reported on by several media sources.14 Perhaps what is surprising, though, is the language of
approval that is used by many major media outlets.14 In acknowledging these reports, one study
mentioned that 95% of articles in the media indicated at least one possible benefit of using
,

58%

effects.14 Obviously, publishing information in such a one-sided manner could be described as
irresponsible, but it does not diminish the fact that the public opinion appears to be in favor of at
least exploring the idea.
Conversely to what media sources might say, the world of academia appears to be taking
a different approach to the issue. For example, in 2012 Duke University implemented a policy
that explicitly prohibits the unauthorized use of prescription medication for the purpose of
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enhancing academic performance.14 In fact, the university added this new policy under the
.

14 Interestingly,

the study pointing out this change made the point

that by virtue of labeling a policy in such a manner, it is assumed that prescription stimulants do
,
science.14
Academic policies such as this one raise yet another important question: Should the use
of prescription stimulants for the purpose of cognitive enhancement be compared to steroid use
amongst athletes? This concept definitely has room for debate in all aspects of society, and, upon
recognizing the dangers associated with these medications, should be a view through a scope of
fairness and equal opportunity. The AAN argues that if given a more accessible place in society,
prescription stimulants would undoubtedly be viewed as elective medications by insurance
companies and consequently not be covered.25 The resulting situation would then concern
affordability, meaning that only a few members of society would be able to afford their use, thus
creating yet another disadvantage for the more marginalized members of society.25 In an effort to
acknowledge the present racial tensions in the United States and the potential disparities that
could arise as a result of societal acceptance regarding these medications, one study stated,
... B
,
cognitive enhancing drugs are indeed seen by some as a tool for academic advancement more
often wielded by the priv

.
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In closing, this discussion section identified several pitfalls that weakened many current
studies while emphasizing the importance of using concordant terminology, psychological
assessments, cognitive baselines, and confirming either the presence or absence of a diagnosis of
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ADHD in participants. Furthermore, in acknowledging the likelihood that prescription stimulants
will continue to be misused, several ethical questions were addressed regarding the role of
healthcare professionals as medication gatekeepers, a comparison of the risks versus benefits of
prescription stimulant use, and their presence in academia and society. In the end, it is crucial
that debate and research surrounding this topic continue to advance in order to arrive at more
conclusive answers.
Conclusion
The goal of this literature review has been to investigate and blend together the current
research surrounding the misuse and potential cognitive benefits of prescription stimulants. In
doing so, it was made clear that the misuse of prescription stimulants has been on the rise due to
a widespread belief that they convey certain cognitive enhancing properties. Misuse was noted to
be of particular prominence amongst college students, who tend to use them to improve
academic performance, especially when faced with stress related to increased workloads.
However, despite popular belief, there has yet to be a unanimous consensus amongst studies
showing a definitive correlation between prescription stimulant use and enhanced cognition.
While nearly all studies resulted in mild to moderate enhancement of attention, results regarding
other cognitive domains such as memory, executive function, and processing speed were highly
mixed. Public health concerns arise when considering these increasing rates of misuse in spite of
unclear results surrounding the efficacy of prescription stimulants and it becomes all the more
important to further investigate the matter. It is then essential that future studies implement
shared definitions of key terms, identify standard cognitive baselines, and selectively perform
standardized assessments.
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Ethical debates comparing the use of prescription stimulants to doping and cheating is
also worth mentioning. Not only are there certain dangers associated with the use of these
medications, but questions of fairness and their potential for increasing the inequality gap is
certainly important and the public view on this matter needs be explored. Perhaps the most
important ethical consideration pertains to college students, being that misuse is primarily
motivated by academic advancement. Students posed with misusing prescription stimulants must
,

,

consequences, their potential to self-motivate without the use of a substance in the future, and
their own moral code.
Lastly, the current research and ethical debate was followed up with a discussion
regarding the role and responsibility healthcare professionals hold with these medications.
Obviously, healthcare professionals are the gatekeepers to all prescription drugs. It is therefore
immensely important to use good diagnostic and judgement skills in identifying true ADHD
patients while also taking into consideration what potential benefits, if any, a healthy, nonADHD patient might see from using prescription stimulants. In these considerations, it is clearly

weigh the risks of potential adverse effects that could occur while using prescription stimulants.
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